Core Viewpoint - Beijing Ruimait Medical Technology Co., Ltd. is experiencing a decline in stock price, with a drop of 2.36% on November 13, resulting in a market capitalization of 7.437 billion yuan and a trading volume of 123 million yuan [1]. Company Overview - The company specializes in the manufacturing of medical devices and consumables in the field of respiratory health, including various types of sleep apnea machines and monitoring devices [2][7]. - As of September 30, the company reported a revenue of 808 million yuan for the first nine months of 2025, representing a year-on-year growth of 34.24%, and a net profit of 180 million yuan, up 43.87% year-on-year [8]. Financial Performance - The company's overseas revenue accounts for 64.21% of total revenue, benefiting from the depreciation of the RMB [3]. - The main business revenue composition includes 64.19% from home respiratory therapy products, 32.67% from consumables, and 3.05% from medical products [7]. Shareholder and Market Activity - As of September 30, the number of shareholders increased by 16.36% to 7,971, while the average circulating shares per person decreased by 14.20% to 7,080 shares [8]. - The stock has seen a net outflow of 11.24 million yuan from major investors, indicating a lack of strong control over the stock by major players [4][5]. Investment and Partnerships - The company holds a 14.28% stake in Deda Xingshu, a leading domestic provider of precision motors and solutions, which is involved in AI, robotics, and medical applications [3].
瑞迈特跌2.36%，成交额1.23亿元，近5日主力净流入-664.38万